Back to News
Market Impact: 0.15
Enlivex Therapeutics Ltd. Announces 1-for-16 Reverse Share Split Effective October 27, 2026
Source: Nasdaq
Company Fundamentals
Enlivex Therapeutics’ board approved a 1-for-16 reverse split of its ordinary shares. The shares are scheduled to begin trading on a split-adjusted basis on the Nasdaq Capital Market on October 27, 2026.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
ENLV-0.20
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
- Volvo Cars shares plunge 25% amid China sales slump and fresh job cuts